A phase II/III trial of fixed dose combination of amantadine, oseltamivir and ribavirin (ADS-8902) for the treatment of severe influenza.
Phase of Trial: Phase II/III
Latest Information Update: 14 Sep 2017
At a glance
- Drugs Amantadine/oseltamivir/ribavirin (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- 14 Sep 2017 New trial record